Domů › Mnohočetný myelom › Pennsylvania › Philadelphia
Klinické studie Mnohočetný myelom v Philadelphia, PA
16 studií pro Mnohočetný myelom hledá účastníky v lokalitách v Philadelphia a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Probíhá náborFáze 1
- University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine, Philadelphia
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Probíhá náborFáze 3
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Probíhá náborFáze 4
- University of Pennsylvania, Philadelphia
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
Probíhá náborFáze 1/2
- Penn Medicine, Philadelphia
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Probíhá náborFáze 2
- Fox Chase Cancer Center, Philadelphia
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Probíhá náborFáze 2
- Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Probíhá náborFáze 1/2
- Research Site, Philadelphia
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Probíhá náborFáze 3
- Thomas Jefferson University Hospital, Philadelphia
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Probíhá náborFáze 1
- University of Pennsylvania, Philadelphia
Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment
Probíhá náborFáze 1/2
- ECOG-ACRIN Cancer Research Group, Philadelphia
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Probíhá náborFáze 1/2
- Penn Medicine - Abramson Cancer Center Perelman, Philadelphia
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Probíhá nábor
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Probíhá náborFáze 3
- Abramson Cancer Center University of Pennsylvania Medical Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Probíhá náborFáze 1/2
- Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Mozobil for Autologous Hematopoietic Stem Cell Transplantation
Probíhá náborFáze 2
- Thomas Jefferson University Hospital, Philadelphia
Limited-duration Teclistamab
Probíhá náborFáze 2
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
Studie Mnohočetný myelom v jiných městech
- New York City, NY60 studií
- Boston, MA42 studií
- Atlanta, GA41 studií
- Houston, TX38 studií
- Durham, NC37 studií
- Nashville, TN32 studií
- Denver, CO27 studií
- Rochester, MN24 studií
- St. Louis, MO24 studií
- Columbus, OH24 studií
- Baldwin Park, CA23 studií
- Chicago, IL22 studií
Další studie v Philadelphia
- Rakovina (všechny typy)59 studií
- Rakovina prsu56 studií
- Nemalobuněčný plicní karcinom51 studií
- Metastatický karcinom46 studií
- Kolorektální karcinom44 studií
- Rakovina vaječníků44 studií
- Rakovina prostaty44 studií
- Rakovina plic36 studií
- Akutní myeloidní leukemie34 studií
- Srdeční selhání31 studií
- Rakovina endometria28 studií
- Deprese26 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.